Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
business
business sponsored company news
big data
articles containing video clips
cloud
colloids
dosage forms
drug delivery devices
gadgets
gels
health
health care
histopathology
infectious causes of cancer
machine learning
male genital neoplasia
neoplastic and hyperplastic prostate disorders
physical chemistry
prostate cancer
rtt
accenture technology vision
alphabet
american medical association
anaerobic digestion
analytics
apps
biodegradable waste management
biodegradation
companies based in minneapolis
companies established in 1895
companies listed on the new york stock exchange
deals
fda
health care ai
healthtech
illinois
investment banks
medical
medical and health professional associations in chicago
medical devices
What
risk
24
×
company
medical
technology
augmenix
develops
hydrogels
manufactures
organs
press
protect
radiotherapy
release
sells
separate
absorbable
proprietary
announced
today
prostate
announces
hydrogel
spaceoar
cancer
data
health
new
patients
annual
medicine
radiation
american
conference
healthcare
patient
present
treated
use
year
alzheimer’s
Language
Current search:
venturebeat.com
×
risk
×
@venturebeat.com
5 years ago
Cytox Launches Collaboration Agreement with Mayo Clinic to Evaluate Novel Genetic Based Approaches for Assessing Alzheimer’s Risk
@venturebeat.com
5 years ago
Cytox in Collaboration with AKESOgen Extends Genetic Test for Assessing Alzheimer’s Risk to Include Saliva Samples
@venturebeat.com
6 years ago
‘Citizen AI’: Teaching artificial intelligence to act responsibly
@venturebeat.com
6 years ago
Augmenix to Present at the 36th Annual J.P. Morgan Healthcare Conference
@venturebeat.com
6 years ago
Clew Medical is using AI to identify patients at risk
@venturebeat.com
6 years ago
Augmenix® Announces Medicare Reimbursement Rates for the new CPT Code 55874, which will be used to bill SpaceOAR® Hydrogel, Effective January 2018
@venturebeat.com
6 years ago
Augmenix Partners with Us TOO International to Stream Live Webcast and Q & A on Prostate Cancer Radiation Therapy
@venturebeat.com
6 years ago
Augmenix Announces Positive Clinical Trial Results Demonstrating Efficacy of SpaceOAR
@venturebeat.com
6 years ago
Augmenix to Unveil New Clinical Data on its Innovative Absorbable Hydrogel Technology at the 59th Annual Meeting of the American Society for Radiation Oncology
@venturebeat.com
6 years ago
NICE Announces Interventional Procedure Guidance Supporting Use of Hydrogel Spacer in Treatment of Prostate Cancer in the UK
@venturebeat.com
6 years ago
Augmenix, Inc. Announces Medicare Administrative Contractor Palmetto Coverage for SpaceOAR® Hydrogel
@venturebeat.com
6 years ago
Augmenix Ranked as One of America’s Fastest-Growing Private Companies for Second Year
@venturebeat.com
6 years ago
Augmenix Announces First Prostate Cancer Patients Treated with SpaceOAR® Hydrogel in Israel
@venturebeat.com
6 years ago
Augmenix Announces First Prostate Cancer Patient Treated with SpaceOAR® Hydrogel in New Zealand
@venturebeat.com
6 years ago
SpaceOAR® System Receives Shonin Approval in Japan
@venturebeat.com
6 years ago
Augmenix Announces First Prostate Cancer Patient Treated with SpaceOAR® Hydrogel in Canada
@venturebeat.com
7 years ago
Alphabet’s life sciences division Verily launches study to track health data
@venturebeat.com
7 years ago
Phase 3 Trial Data Show Use of SpaceOAR® Hydrogel Helps Maintain Erectile Function Following Prostate Cancer Radiation Treatment
@venturebeat.com
7 years ago
Augmenix Announces Positive Three-Year Long-Term Data Highlighting Benefits of SpaceOAR® Hydrogel Spacer for Patients with Prostate Cancer
@venturebeat.com
7 years ago
Augmenix To Present at the 35th Annual J.P. Morgan Healthcare Conference
@venturebeat.com
7 years ago
Augmenix to Present at the Annual Piper Jaffray Healthcare Conference on Wednesday, November 30
@venturebeat.com
7 years ago
Augmenix Announces New Category 1 CPT® Code from the American Medical Association for Periprostatic Implantation of Biodegradable Material
@venturebeat.com
9 years ago
FDA releases guidance on regulation of ‘wellness’ med devices and accessories
@venturebeat.com
9 years ago
Proteus Digital Health takes in another $52M for meds-monitoring system